Corrigendum to “Anti-anginal drugs: Systematic review and clinical implications” [Int. J. Cardiol. 283 (2019) 55–63] (International Journal of Cardiology (2019) 283 (55–63), (S0167527318360947), (10.1016/j.ijcard.2018.12.008))

Rita Pavasini, Paolo G. Camici, Filippo Crea, Nicolas Danchin, Kim Fox, Athanasios J. Manolis, Mario Marzilli, Giuseppe M.C. Rosano, José L. Lopez-Sendon, Fausto Pinto, Cristina Balla, Roberto Ferrari

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors regret <8Clinical Academic Group, St George's Hospitals NHS Trust, Blackshaw Road, London SW17 0QT, UK; Department of Medical Sciences, IRCCS San Raffaele, Via della Pisana, 235, 00163 Rome, Italy>. Please substitute with 8Centre for Clinical and Basic Research, Department of Medical Sciences, IRCCS San Raffaele Pisana, Rome, Italy The author would like to apologise for any inconvenience caused.

Original languageEnglish
Pages (from-to)23
Number of pages1
JournalInternational Journal of Cardiology
Volume321
DOIs
Publication statusPublished - Dec 15 2020

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Corrigendum to “Anti-anginal drugs: Systematic review and clinical implications” [Int. J. Cardiol. 283 (2019) 55–63] (International Journal of Cardiology (2019) 283 (55–63), (S0167527318360947), (10.1016/j.ijcard.2018.12.008))'. Together they form a unique fingerprint.

Cite this